| |
| | |  Advertisement | | |
| |
July 16, 2008 10:42 IST
Ranbaxy [Get Quote] chairman Malvinder Singh has denied USFDA allegations. "We have done intensive examinations of all issues and we are committed to providing drugs at reasonable prices to consumers, he said.
"A lot of speculation in the market due to lack of information," Singh added.
Ranbaxy to file response within a month
© Copyright 2008 PTI. All rights reserved. Republication or redistribution of PTI content, including by framing or similar means, is expressly prohibited without the prior written consent.
|
| |
Email | 
Print | Get latest news on your desktop